Ventricular dysrhythmias following an alfentanil anesthetic in a patient on reserpine for hypertension.
The case is presented of a hypertensive patient on reserpine, who developed ventricular irritability after administration of alfentanil, a new ultra-short-acting narcotic used in anesthesia. The dysrhythmias resolved after cessation of the offending agent. There are no reported cases of interaction of reserpine and alfentanil in the literature.
Jahr
J S
JS
Department of Anesthesiology, Tulane University School of Medicine, New Orleans, Louisiana.
Weber
S
S
D015760:Alfentanil / Q000009:adverse effects*; D000771:Anesthesia, Intravenous / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001919:Bradycardia / Q000139:chemically induced; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D012110:Reserpine / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced; D016276:Ventricular Function
D015760:Alfentanil; D012110:Reserpine